Vista Therapeutics

Nanotechnology Research • Santa Fe, New Mexico, United States • 1-10 Employees

Company overview

Headquarters	3900 Paseo Del Sol, Santa Fe, NM 87507, US
Website	vistatherapeutics.org
NAICS	541713
Keywords	Research, Diagnostic, PCR, Toxicology, Pk/Pd, Sensor, Cell Culture, Bioprocessing, Environmental Monitoring, Point Of Care, FET, Biomarker Analysis, Biosensor Development, Cancer Biomarker, Field-Effect Transistor, Functionalized Kit, Label Free Detection, Rtpcr
Employees	1-10

Key Contact at Vista Therapeutics

Spencer Farr

Founder and Chief Scientific Officer

About Vista Therapeutics

Vista Therapeutics has been developing, collaborating, and fine tuning the NanoBioSensorTM Platform based on research developed in the Charles M. Lieber Laboratory at Harvard University. The software, instrument, and functionalized NanoCards for target immobilization are based on silicon nanowires that act as Field Effect Transistors (FETs) to quantitatively measure and provide kinetic analysis of real time changes in conductance with high sensitivity based on detector:target sample interactions without requiring secondary detection molecules. Applications include: -Multiplex biomarker measurement in body fluids and cell culture matrices -Bioprocess monitoring -Toxicology/Pharmacokinetics -Portable option for field based diagnostics -Pathogen detection -Environmental monitoring -Historical exposure/vaccine analyis (IgM or IgG formation) -PCR/rtPCR coming soon...

Vista Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Nanotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Vista Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Vista Therapeutics has never raised funding before.